| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.97 | 0.002 | 0.97 | Psychostimulant | 0.932 0.002 DBMET00398 | ||
| 0.947 | 0.003 | 0.956 | Tubulin antagonist | 0.956 0.003 DBMET00398 | DBMET00398 | |
| 0.807 | 0 | 0.858 | Antineoplastic alkaloid | 0.858 0 DBMET00398 | DBMET00398 | |
| 0.805 | 0.004 | 0.805 | Antimitotic | 0.797 0.004 DBMET00398 | ||
| 0.728 | 0.004 | 0.728 | Hypoxia-inducible factor 1 alpha inhibitor | 0.663 0.005 DBMET00398 | ||
| 0.661 | 0.003 | 0.715 | Beta tubulin antagonist | 0.715 0.003 DBMET00398 | DBMET00398 | |
| 0.623 | 0.003 | 0.623 | Alpha tubulin antagonist | 0.57 0.004 DBMET00398 | ||
| 0.513 | 0.008 | 0.513 | P-glycoprotein inhibitor | 0.476 0.01 DBMET00398 | ||
| 0.451 | 0 | 0.451 | Microtubule formation inhibitor | 0.414 0.001 DBMET00398 | ||
| 0.43 | 0.1 | 0.43 | Apoptosis agonist | 0.409 0.11 DBMET00398 | ||
| 0.254 | 0.005 | 0.304 | Folate antagonist | 0.304 0.003 DBMET00398 | DBMET00398 | |
| 0.258 | 0.031 | 0.258 | Lipocortins synthesis antagonist | 0.243 0.036 DBMET00398 | ||
| 0.275 | 0.08 | 0.275 | Spasmolytic | 0.16 0.154 DBMET00398 | ||
| 0.291 | 0.121 | 0.291 | Immunosuppressant | 0.228 0.168 DBMET00398 | ||
| 0.169 | 0.036 | 0.177 | MAP3K9 inhibitor | 0.177 0.029 DBMET00398 | DBMET00398 | |
| 0.139 | 0.046 | 0.139 | Topoisomerase I inhibitor | 0.139 0.046 DBMET00398 | ||
| 0.1 | 0.045 | 0.1 | Acetylcholine M3 receptor agonist | 0.093 0.05 DBMET00398 | ||
| 0.093 | 0.049 | 0.099 | Antineoplastic antibiotic | 0.099 0.047 DBMET00398 | DBMET00398 | |
| 0.129 | 0.098 | 0.129 | Insulin secretagoues | |||
| 0.061 | 0.033 | 0.061 | Lipocortins synthesis agonist | 0.059 0.037 DBMET00398 | ||
| 0.127 | 0.106 | 0.164 | Sigma receptor agonist | 0.164 0.076 DBMET00398 | DBMET00398 | |
| 0.037 | 0.019 | 0.037 | Squalene synthetase inhibitor | 0.03 0.024 DBMET00398 | ||
| 0.054 | 0.037 | 0.059 | Acetylcholine M2 receptor agonist | 0.059 0.03 DBMET00398 | DBMET00398 | |
| 0.132 | 0.116 | 0.132 | Nitric oxide antagonist | |||
| 0.212 | 0.2 | 0.212 | 15-Lipoxygenase inhibitor | |||
| 0.075 | 0.066 | 0.075 | Opioid kappa receptor antagonist | 0.073 0.07 DBMET00398 | ||
| 0.072 | 0.066 | 0.072 | Acetylcholine nicotinic antagonist | |||
| 0.226 | 0.233 | 0.257 | Calcium channel L-type activator | 0.257 0.197 DBMET00398 | DBMET00398 | |
| 0.109 | 0.124 | 0.118 | Cholinergic | 0.118 0.111 DBMET00398 | DBMET00398 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |